“The new AIDS trial vaccine already was tested successfully (on mice) and now we are preparing a very small, tightly controlled phase one clinical trial”with HIV-positive patients who are not in the advanced stages of disease, researcher Enrique Iglesias said. – File Photo AFP

HAVANA: Cuba’s top biotech teams have successfully tested a new AIDS vaccine on mice, and are ready to soon begin human testing, a leading researcher told a biotechnology conference in Havana on Monday.

“The new AIDS trial vaccine already was tested successfully (on mice) and now we are preparing a very small, tightly controlled phase one clinical trial”with HIV-positive patients who are not in the advanced stages of disease, researcher Enrique Iglesias said.

Iglesias, who heads up the vaccine development team at the Biotech and Genetic Engineering Center (CIGB) here, was speaking at the International Biotech Conference-Havana 2012, which started Monday in Cuba’s capital.

He told the crowd at the convention center that the vaccine TERAVAC-HIV-1 was made from recombinant proteins aiming “to cause a cellular response against the (HIV) virus.”While upbeat, the Cuban expert was quick to downplay high hopes for a long-awaited successful AIDS vaccine.

“So far, there have been more than 100 clinical tests (on humans) with HIV” in Cuba and other countries, “and all of them have failed,” he stressed.

Cuba, the Americas’ only one-party Communist-ruled state, spends more than $200 million a year on its AIDS prevention and care programs, including free care with antiretrovirals, some of them Cuban-made.

The CIGB, which groups about 20 research units on Havana’s leafy western end, is the engine behind a major Cuban export: biotech products including vaccines and other drugs.

The Caribbean country exports $400 million a year in these products, making them its official number-two export after nickel.

Some 600 scientists from about 38 countries are taking part in the event including Nobel-winning US chemist Peter Agre, also a medical doctor and molecular biologist.

Opinion

Editorial

Horror in Sialkot
Updated 05 Dec 2021

Horror in Sialkot

All it takes now is an allegation of blasphemy and an individual or two to incite a mob to commit murder.
05 Dec 2021

Iran deadlock

EFFORTS to revive the landmark 2015 Iran nuclear deal in the Austrian capital of Vienna appear to be deadlocked, and...
05 Dec 2021

Reality of AIDS

AS World AIDS Day was marked on Dec 1, it came as a sobering reminder of how newer, major health hazards — the...
Stock market carnage
Updated 04 Dec 2021

Stock market carnage

PAKISTAN’S stock market has been on a downward ride for the last several months as a result of deteriorating...
04 Dec 2021

Omicron threat

THE NCOC has suggested installing more oxygen plants in various parts of the country as the new Covid-19 variant,...
04 Dec 2021

UK spymaster speaks

A RECENT speech by the chief of MI6 — the UK’s external intelligence agency — provided a key insight into the...